Advertisement

Topics

Proneuron Biotechnologies Company Profile

09:36 EDT 22nd September 2018 | BioPortfolio

Proneuron Biotechnologies is a biopharmaceutical company developing therapies for neurological disorders, including spinal cord injuries (SCI), brain trauma, and neurodegenerative diseases such as ALS, Huntington’s and Alzheimer’s diseases. The brain, spinal cord and optic nerves comprise the central nervous system (CNS) one of the most complex and enigmatic systems in nature. The CNS is responsible for consciousness, memory, intelligence, the five senses, and controlled movement. However, these functions may be disrupted by brain damage, spinal injury or disease, causing severe disability, such as paralysis, blindness, or loss of mental capabilities. The disability is often permanent because the CNS has a very limited capacity for healing and self repair.While there is no paralysis cure yet available to treat spinal cord injury, nor any cure for CNS trauma in general, scientists at the Weizmann Institute of Science and Proneuron have demonstrated that CNS recovery may be enhanced by applying the body’s own repair system, the immune system, which is actively involved in wound-healing in other parts of the body. In the quest for a paralysis cure, Proneuron is pursuing an aggressive research and development program based on proprietary immune-modulating technology. Proneuron's lead product is ProCord, an experimental cell therapy that is being developed to treat acute spinal cord injury. Besides spinal cord injuries, additional products are being developed for other debilitating neurological indications

Location

Weizmann Science Park, Building 14,P.O.B. 277
Ness-Ziona
74101
Israel

Contact

Phone: 972-8-9409550
Fax: 972-8-9409560
Email: information@proneuron.com


News Articles [110 Associated News Articles listed on BioPortfolio]

Deals this week: Refuge Biotechnologies, Attenua, Crescendo Biologics

US-based Refuge Biotechnologies Inc has raised $25m in a series B funding round led by 3SBio and Sequoia China. The...Read More... The post Deals this week: Refuge Biotechnologies, Attenua, Crescendo ...

INVITROGEN MOTHER E-BASE BY ETHROG BIOTECHNOLOGIES

$35.00End Date: Friday Aug-3-2018 5:25:47 PDTBuy It Now for only: $35.00Buy It Now | Add to watch list Biotech365 : INVITROGEN MOTHER E-BASE BY ETHROG BIOTECHNOLOGIES BioMarketplace You want to p...

Elanix Biotechnologies: Erfolgreiche Finanzierungsrunde

Ende Mai hat Elanix Biotechnologies eine Kapitalerhöhung angekündigt, heute kommt die Vollzugsmeldung der Berliner. Die Gesellschaft hat fast 0,68 Millionen Aktien ausgegeben. Der Bezugspreis je Ak....

Aegea Biotechnologies' next generation nucleic acid clinical diagnostic technologies gets US, Australian & Chinese patents

Aegea Biotechnologies, a biotechnology company, announces the issuance of a collection of patents including US Patent 9,428,747 entitled methods for amplification of nucleic acids utilising hairpin lo...

Arbor Biotechnologies Comes Out of Stealth Mode

Arbor Biotechnologies came out of stealth mode yesterday with a $15.6 million Series A financing round.

SQZ Biotechnologies Closes Oversubscribed $72 Million Series C

Watertown, Massachusetts-based SQZ Biotechnologies completed an oversubscribed Series C financing worth $72 million. New investors included Everblue, Illumina Ventures, Invus, Orient Life, and Viva Ve...

TriLink BioTechnologies to relocate to expand operations

TriLink BioTechnologies, a subsidiary of Maravai, that provides gene therapy services to researchers, has announced it will relocate to expand the companyâs operations.

CEO Salzman, CMO Contouriotis Resign from Adverum Biotechnologies

Amber Salzman has resigned from her position as president and CEO of Adverum Biotechnologies (NASDAQ: ADVM) effective May 3. She has also stepped down from the Menlo Park, CA, gene therapy developer...

Drugs and Medications [0 Results]

None

PubMed Articles [15 Associated PubMed Articles listed on BioPortfolio]

Dental, Oral, and Craniofacial Regenerative Medicine: Transforming Biotechnologies for Innovating Patient Care.

Biological sulfur oxidation in wastewater treatment: A review of emerging opportunities.

Sulfide prevails in both industrial and municipal waste streams and is one of the most troublesome issues with waste handling. Various technologies and strategies have been developed and used to deal ...

High-throughput optimisation of light-driven microalgae biotechnologies.

Microalgae biotechnologies are rapidly developing into new commercial settings. Several high value products already exist on the market, and systems development is focused on cost reduction to open up...

Integrating Proteins in Layer-by-Layer Assemblies Independently of their Electrical Charge.

Layer-by-layer (LbL) assembly is an attractive method for proteins immobilization at interfaces, a much wanted step for e.g. biotechnologies and biomedicine. Integrating proteins in LbL thin films is ...

Recent Advances in Liquid Metal Manipulation toward Soft Robotics and Biotechnologies.

Interest has grown significantly in the field of soft robotics, which seeks to develop machinery capable of duplicating the elastic and rheological properties of typically polymeric or elastomeric bio...

Clinical Trials [0 Results]

None

Companies [105 Associated Companies listed on BioPortfolio]

Proneuron Biotechnologies (Israel) Limited

Proneuron Biotechnologies is developing therapies for neurological, ophthalmologic and immune-related disorders such as spinal cord injuries, multiple sclerosis, glaucoma, Parkinson's disease and Alzh...

Proneuron Biotechnologies

Proneuron Biotechnologies is a biopharmaceutical company developing therapies for neurological disorders, including spinal cord injuries (SCI), brain trauma, and neurodegenerative diseases such as ALS...

RAN Biotechnologies

Based in Beverly, MA, USA, RAN Biotechnologies, Inc., www.ranbiotechnologies.com, provides chemicals specially optimized for microfluidic and biotechnological applications. Partic...

Open Therapeutics

Open Therapeutics (http://OpenTherapeutics.org) is a crowdsourcing life science firm that creates and attracts therapeutic biotechnologies and crowdsources them for the global ...

Genemed Biotechnologies Incorporated

Genemed Biotechnologies Inc. provides high quality contract manufacturing services for a wide variety of research and diagnostic products including native or recombinant proteins and nucleotides

More Information about "Proneuron Biotechnologies" on BioPortfolio

We have published hundreds of Proneuron Biotechnologies news stories on BioPortfolio along with dozens of Proneuron Biotechnologies Clinical Trials and PubMed Articles about Proneuron Biotechnologies for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Proneuron Biotechnologies Companies in our database. You can also find out about relevant Proneuron Biotechnologies Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Spinal Cord Disorders
The spinal cord is a bundle of nerves that runs down the middle of the back which carry signals back and forth between the body and brain. It is protected by vertebrae, which are the bone disks that make up the spine. An accident that damages the verte...


Corporate Database Quicklinks



Searches Linking to this Company Record